The program was developed to be run in phases, so it wasn't stopped because of a lack of resources. It simply has run through the course of phase 2b, which was one of the planned phases. The next phase was supposed to be phase 3, where we were basically going to do disease challenge studies on the understudied agents that came out to be the most impactful from phase 2b.
We have to source new funding and facilities to do those research challenges. It's not certain that the Pacific Salmon Foundation or Genome BC will necessarily be involved. So we need to find new partners. It's not necessarily dead; it just means that we have to start over again and make a new program.